For Immediate Release: October 19, 2011
Contact: Arthur Combs, CEO
Cell: 314 341 3444, [email protected]
WORCESTER, MA – Grove Instruments Inc., a medical device company based in Worcester, MA developing the world’s first noninvasive glucometer today announced that William Tamborlane, MD, Professor of Pediatrics, Chief of Pediatric Endocrinology and Deputy Director Yale Center for Clinical Investigation at Yale University is joining the Company’s Scientific Advisory Board. “We’re building a world class Advisory Board to guide the development and clinical testing of our transformative noninvasive glucometer,” said Arthur Combs, CEO of Grove. Bill joins Dr. Antoine Kaldany of the Harvard Medical Faculty Physicians and the Joslin Clinic as well as Dr. Craig Mello, renowned molecular biologist and Nobel Laureate, whose passion for diabetes care emanates from personal family experience.
Dr. Tamborlane’s research effort is primarily directed at the translation of advances in diabetes technology into improved patient care for patients with diabetes. He serves as Co-Chair of the Juvenile Diabetes Foundation Continuous Glucose Monitoring Study Group that has carried out multi-center trials of continuous glucose sensors to improve diabetes care in patients of all ages.
In 2006 Dr. Tamborlane received the prestigious Mary Tyler Moore and S. Robert Levine Excellence in Clinical Research Award from the Juvenile Diabetes Research Foundation International. In 2009 he received the Diabetes Technology Society Leadership Award and in 2010 he was the recipient of the American Diabetes Association’s Outstanding Clinician Physician in Diabetes Award.
“Caring for children and adolescents with type 1 diabetes is a most demanding field of medicine. Dr. William Tamborlane has long been a role model as a dedicated clinician, teacher and innovator in the field. It is a great privilege for me to welcome Dr. Tamborlane to Grove’s Scientific Advisory Board,” said Dr. Tony Kaldany of the Joslin Clinic. Art Combs, Grove CEO said that “this is a propitious time to have such recognized experts advising the company. We’re thrilled to have Bill join the Advisory Board.”
About Grove Instruments
Grove Instruments, Inc. is a privately held pre-market medical device company developing the world’s first noninvasive glucometer with the potential to exceed the ISO standard for blood glucose meters. Grove’s patented technology is based on the seminal concept of the Optical Bridge and is unique among all NIR spectroscopic approaches to noninvasive blood glucose determination. The Company has been recognized for its innovation, technology development and clinical results on 10 separate occasions by the NIH NIDDK with funded SBIR Grants. In 2011, Grove was also recognized by the Massachusetts Life Sciences Center with an Accelerator Award – one of only 4 recipients out of all Boston-area life sciences companies applying in that round. For more information see www.groveinstuments.com or contact Arthur Combs (314 341 344 mobile).
